Ir.skyebioscience.com

Skye Bioscience Reports that Emerald Health Therapeutics …

San Diego, California, Aug. 19, 2022 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye” or the “Company”), a pharmaceutical company developing a proprietary, synthetic cannabinoid derivative to treat glaucoma, reports that the shareholders of Emerald Health Therapeutics, Inc. ("Emerald" or the "Company") (CSE: EMH; OTCQB: EMHTF) today approved the proposed plan of

Actived: 4 days ago

URL: https://ir.skyebioscience.com/news-events/press-releases/detail/140/skye-bioscience-reports-that-emerald-health-therapeutics

Emerald Bioscience Launches Rebrand Including Name Change to …

WebName change reflects Company’s evolution, renewed team and strategic focus on advancing its lead compound into human trials Company to trade under ticker SKYE …

Category: Health Go Health

Skye Bioscience Closes Acquisition of Emerald Health Therapeutics

WebSan Diego, California-- (Newsfile Corp. - November 10, 2022) - Skye Bioscience, Inc. (OTCQB: SKYE) ("Skye" or the "Company"), a pharmaceutical company developing a …

Category: Health Go Health

Investor Relations :: Skye Bioscience, Inc. (SKYE)

WebBacked by specialist life science investors, Skye's strategy leverages biologic targets with substantial human proof of mechanism for the development of first-in-class …

Category: Health Go Health

Skye Bioscience Stockholders Vote in Favor of Arrangement …

WebAdditional capital from Arrangement Agreement expected to fund Skye's Phase 1 and 2 clinical studies of proprietary synthetic cannabinoid-derivative therapeutic …

Category: Health Go Health

Skye Bioscience Receives FDA Authorization of Investigational …

WebPhase 2 clinical trial planned to start in H1 2023. San Diego, California--(Newsfile Corp. - December 20, 2022) - Skye Bioscience, Inc. (OTCQB: SKYE) ("Skye" …

Category: Health Go Health

Company Information :: Skye Bioscience, Inc. (SKYE)

WebCompany Contact Skye Bioscience, Inc. 11250 El Camino Real Suite 100 San Diego, CA 92130

Category: Health Go Health

Skye Bioscience Establishes New Cannabinoid Pharmaceutical …

WebExclusive sponsored research agreement with endocannabinoid research pioneers. SAN DIEGO, CA, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Skye Bioscience, …

Category: Health Go Health

Emerald Bioscience Announces Financing Update and Board Re …

WebEmerald Health Sciences To Exercise 40.8 Million Warrants, Reducing Outstanding Debt, As Company Changes Name to Embi Pharmaceuticals Punit Dhillon Assumes Board …

Category: Health Go Health

News & Events :: Skye Bioscience, Inc. (SKYE)

WebSkye Bioscience Announces $40 Million Private Placement Equity Financing. Mar 4, 2024 7:00am EST.

Category: Health Go Health

Skye Completes $17M Financing and Acquires Novel Phase 2 …

WebAcquisition of Bird Rock Bio builds Skye's position as a leading endocannabinoid system-focused pharmaceutical company. New capital funds …

Category: Health Go Health

Skye Bioscience Appoints Chris Twitty, PhD, as Chief Scientific Officer

WebSan Diego, California--(Newsfile Corp. - December 13, 2022) - Skye Bioscience, Inc. (OTCQB: SKYE) ("Skye" or the "Company"), a pharmaceutical company …

Category: Health Go Health

Emerald Health Therapeutics and Skye Bioscience Announce …

WebSkye will continue to pursue Canadian Securities Exchange listing following closing of transaction. Vancouver, British Columbia--(Newsfile Corp. - November 7, …

Category: Health Go Health

Nemus Bioscience Announces that Emerald Health Sciences has …

WebAvtar Dhillon, MD, appointed as Executive Chairman of Nemus. LONG BEACH, CA, Oct. 08, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Nemus …

Category: Health Go Health

Skye Bioscience Signs Arrangement Agreement with Emerald …

WebArrangement is expected to fund Skye’s proprietary synthetic cannabinoid-derivative therapeutic initially targeting glaucoma for first Phase 2 clinical study

Category: Health Go Health

Nemus Secures Emerald Health as Strategic Majority Investor to …

WebNemus Bioscience Receives $400,000 Funding under Convertible Bridge Loan and Closes Initial $1,500,000 Private Placement. COSTA MESA, Calif., Jan. 19, 2018 (GLOBE …

Category: Health Go Health

News Releases :: Skye Bioscience, Inc. (SKYE)

WebSkye Bioscience Announces $50.25 Million Private Placement Equity Financing. Jan 09, 2024 7:00am EST.

Category: Health Go Health

Skye Bioscience Reverse Stock Split to Be Effective on September 8th

WebEach fractional share will be rounded up to one whole share. The new CUSIP for the common stock following the reverse stock split will be 83086J200. Following the …

Category: Health Go Health

Emerald Health, Strategic Majority Investor in Nemus Bioscience

WebNemus Bioscience Receives $1,750,000 Private Placement to Help Advance Innovative Bio-engineered Cannabinoid Pipeline. Costa Mesa, Calif., Feb. 16, 2018 (GLOBE …

Category: Health Go Health

Top Categories

› Appendicitis

› Gout

› Women's Health

› Thyroid

› Sleep

› Skin

› Sexual Health

› Senior Health

› Oral Health

› Mental Health

› Men's Health

› Medications

› Lung Conditions

› Infectious Disease

Popular Searched

› Advent health gi specialist

› 23andme health report worth it

› Wdg public health booking

› System thinking in healthcare

› Definition of management in health care

› Healthway medical shangri la plaza

› Why is mental health booming

› Signs of gut health

› Emory healthcare holiday list

› Behavioral health continuing medical school

Recently Searched

› South shore eye health services

› Emblemhealth list of doctors

› Trihealth central scheduling fax number

› Macoya health centre website

› Ohio health financial aid

› Breast health center auburn al

› Archwell health provider portal

› Group health five mile rd

› Data analytics health care courses

› Network health insurance mental health providers

The medical information found on the MedRXweb website is designed to support, not to replace the relationship between patient and physician and the medical advice they may provide.